한글목차

세계의 키나아제 스크리닝 및 프로파일링 서비스 시장은 2024년에 3억 7,012만 달러로 평가되었으며, 2030년까지 CAGR 5.55%로 성장하여 5억 1,179만 달러에 달할 것으로 예측됩니다.

키나아제 스크리닝 및 프로파일링 서비스는 다양한 치료 영역에서 중요한 약물 표적인 광범위한 키나아제 효소에 대한 화합물의 활성과 선택성을 식별, 특성화, 평가하기 위해 사용되는 전문 생화학 및 세포 기반 분석법을 포함합니다.

주요 시장 촉진요인

만성질환의 증가 추세와 특히 정밀 암 치료 분야에서 맞춤형 의료에 대한 수요 증가는 세계 키나아제 스크리닝 및 프로파일링 서비스 시장의 성장을 견인하는 중요한 요인으로 작용하고 있습니다. 만성질환, 특히 각종 암질환의 발생률이 증가함에 따라 새로운 치료 타겟과 약물을 발굴하기 위한 신약개발 활동이 지속적으로 요구되고 있습니다.

주요 시장 과제

고급 키나아제 스크리닝 및 프로파일링 기술과 관련된 높은 비용은 전 세계 키나아제 스크리닝 및 프로파일링 서비스 시장의 성장에 큰 장벽으로 작용하고 있습니다. 이러한 높은 비용은 수많은 바이오 스타트업과 중소 제약사들에게 최첨단 스크리닝 플랫폼에 대한 접근성을 직접적으로 제한하는 요인으로 작용하고 있습니다.

주요 시장 동향

인공지능(AI)과 머신러닝의 통합은 새로운 치료 화합물 발굴 및 최적화의 효율성과 속도를 크게 향상시킴으로써 키나아제 신약개발을 혁신적으로 변화시키고 있습니다. 이러한 기술을 통해 방대한 데이터세트의 신속한 분석, 키나아제와 리간드의 상호작용 예측, 잠재적 약물 후보물질의 보다 정확한 선별이 가능해집니다.

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 세계의 키나아제 스크리닝 및 프로파일링 서비스 시장 전망

• 시장 규모 및 예측
  • 금액별
• 시장 점유율과 예측
  • 종류별(방사성동위원소법, 균질 비방사성동위원소법)
  • 용도별(기업, 연구기관)
  • 지역별
  • 기업별(2024)
• 시장 맵

제6장 북미의 키나아제 스크리닝 및 프로파일링 서비스 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 북미 : 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제7장 유럽의 키나아제 스크리닝 및 프로파일링 서비스 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 유럽 : 국가별 분석
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인

제8장 아시아태평양의 키나아제 스크리닝 및 프로파일링 서비스 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주

제9장 중동 및 아프리카의 키나아제 스크리닝 및 프로파일링 서비스 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 중동 및 아프리카 : 국가별 분석
  • 사우디아라비아
  • 아랍에미리트
  • 남아프리카공화국

제10장 남미의 키나아제 스크리닝 및 프로파일링 서비스 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 남미 : 국가별 분석
  • 브라질
  • 콜롬비아
  • 아르헨티나

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 인수합병
• 제품 출시
• 최근 동향

제13장 세계의 키나아제 스크리닝 및 프로파일링 서비스 시장 : SWOT 분석

제14장 Porter's Five Forces 분석

• 업계내 경쟁
• 신규 참여의 가능성
• 공급업체의 능력
• 고객의 능력
• 대체품의 위협

제15장 경쟁 구도

• MedChemExpress LLC
• Eurofins Scientific SE
• Thermo Fisher Scientific, Inc.
• Reaction Biology Corp.
• BPS Bioscience, Inc.
• Creative Biogene Inc.
• Luceome Biotechnologies L.L.C.
• Kinexus Bioinformatics Corp.
• LC Sciences LLC
• HD Biosciences Co., Ltd.

제16장 전략적 제안

제17장 조사 회사 소개 및 면책사항

영문목차

The Global Kinase Screening and Profiling Services Market, valued at USD 370.12 Million in 2024, is projected to experience a CAGR of 5.55% to reach USD 511.79 Million by 2030. Kinase screening and profiling services encompass the specialized biochemical and cell-based assays used to identify, characterize, and evaluate the activity and selectivity of compounds against a broad range of kinase enzymes, which are critical drug targets across various therapeutic areas.

Key Market Drivers

The escalating prevalence of chronic diseases and the surging demand for personalized medicine, particularly within precision oncology, are pivotal factors expanding the Global Kinase Screening and Profiling Services Market. The rising incidence of chronic conditions, especially various forms of cancer, necessitates continuous efforts in drug discovery to identify novel therapeutic targets and agents. Kinases represent a crucial class of enzymes implicated in the pathophysiology of numerous chronic diseases, making their inhibition or modulation a significant focus for pharmaceutical development.

Key Market Challenges

The substantial cost associated with advanced kinase screening and profiling technologies presents a significant impediment to the growth of the Global Kinase Screening and Profiling Services Market. These high expenses directly restrict the accessibility of cutting-edge screening platforms for numerous biotechnology startups and smaller pharmaceutical companies. Such organizations frequently operate with constrained research and development budgets, making large investments in specialized, high-throughput screening services financially prohibitive. This limitation often forces them to either defer advanced screening projects or opt for less comprehensive, and therefore less effective, alternatives.

Key Market Trends

Artificial Intelligence and Machine Learning Integration is transforming kinase drug discovery by significantly enhancing the efficiency and speed of identifying and optimizing novel therapeutic compounds. These technologies allow for rapid analysis of vast datasets, prediction of kinase-ligand interactions, and more accurate filtering of potential drug candidates. According to a study published by PharmTech in October 2024, 68% of pharmaceutical experts were utilizing AI and ML in their work, a notable increase from 54% in the previous year.

Key Market Players

• MedChemExpress LLC
• Eurofins Scientific SE
• Thermo Fisher Scientific, Inc.
• Reaction Biology Corp.
• BPS Bioscience, Inc.
• Creative Biogene Inc.
• Luceome Biotechnologies L.L.C.
• Kinexus Bioinformatics Corp.
• LC Sciences LLC
• HD Biosciences Co., Ltd.

Report Scope:

In this report, the Global Kinase Screening and Profiling Services Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Kinase Screening and Profiling Services Market, By Type:

• Radioisotope Method
• Homogeneous Non-radioisotope Method

Kinase Screening and Profiling Services Market, By Application:

• Enterprise
• Research Institute

Kinase Screening and Profiling Services Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Kinase Screening and Profiling Services Market.

Available Customizations:

Global Kinase Screening and Profiling Services Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Kinase Screening and Profiling Services Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Radioisotope Method, Homogeneous Non-radioisotope Method)
  • 5.2.2. By Application (Enterprise, Research Institute)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Kinase Screening and Profiling Services Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Kinase Screening and Profiling Services Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Application
  • 6.3.2. Canada Kinase Screening and Profiling Services Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Application
  • 6.3.3. Mexico Kinase Screening and Profiling Services Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Application

7. Europe Kinase Screening and Profiling Services Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Kinase Screening and Profiling Services Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Application
  • 7.3.2. France Kinase Screening and Profiling Services Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Application
  • 7.3.3. United Kingdom Kinase Screening and Profiling Services Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Application
  • 7.3.4. Italy Kinase Screening and Profiling Services Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Application
  • 7.3.5. Spain Kinase Screening and Profiling Services Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Application

8. Asia Pacific Kinase Screening and Profiling Services Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Kinase Screening and Profiling Services Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Application
  • 8.3.2. India Kinase Screening and Profiling Services Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Application
  • 8.3.3. Japan Kinase Screening and Profiling Services Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Application
  • 8.3.4. South Korea Kinase Screening and Profiling Services Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Application
  • 8.3.5. Australia Kinase Screening and Profiling Services Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Application

9. Middle East & Africa Kinase Screening and Profiling Services Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Kinase Screening and Profiling Services Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Application
  • 9.3.2. UAE Kinase Screening and Profiling Services Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Application
  • 9.3.3. South Africa Kinase Screening and Profiling Services Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Application

10. South America Kinase Screening and Profiling Services Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Application
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Kinase Screening and Profiling Services Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Application
  • 10.3.2. Colombia Kinase Screening and Profiling Services Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Application
  • 10.3.3. Argentina Kinase Screening and Profiling Services Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Kinase Screening and Profiling Services Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. MedChemExpress LLC
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Eurofins Scientific SE
• 15.3. Thermo Fisher Scientific, Inc.
• 15.4. Reaction Biology Corp.
• 15.5. BPS Bioscience, Inc.
• 15.6. Creative Biogene Inc.
• 15.7. Luceome Biotechnologies L.L.C.
• 15.8. Kinexus Bioinformatics Corp.
• 15.9. LC Sciences LLC
• 15.10. HD Biosciences Co., Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer